Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Interest Income - Net (2022 - 2025)

BioRestorative Therapies (BRTX) has disclosed Interest Income - Net for 4 consecutive years, with $57740.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Income - Net fell 63.58% year-over-year to $57740.0, compared with a TTM value of $350609.0 through Sep 2025, down 59.85%, and an annual FY2024 reading of $616077.0, up 11.55% over the prior year.
  • Interest Income - Net was $57740.0 for Q3 2025 at BioRestorative Therapies, down from $73915.0 in the prior quarter.
  • Across five years, Interest Income - Net topped out at $376223.0 in Q4 2023 and bottomed at -$46613.0 in Q2 2022.
  • Average Interest Income - Net over 4 years is $94109.4, with a median of $96187.0 recorded in 2023.
  • Peak annual rise in Interest Income - Net hit 792.61% in 2024, while the deepest fall reached 68.37% in 2024.
  • Year by year, Interest Income - Net stood at $116115.0 in 2022, then skyrocketed by 224.01% to $376223.0 in 2023, then tumbled by 68.37% to $118988.0 in 2024, then plummeted by 51.47% to $57740.0 in 2025.
  • Business Quant data shows Interest Income - Net for BRTX at $57740.0 in Q3 2025, $73915.0 in Q2 2025, and $99966.0 in Q1 2025.